GlaxoSmithKline
GSK
#191
Rank
$74.03 B
Marketcap
$36.16
Share price
2.32%
Change (1 day)
-19.63%
Change (1 year)

Market capitalization of GlaxoSmithKline (GSK)

Market cap: $74.03 Billion

As of February 2023 GlaxoSmithKline has a market cap of $74.03 Billion. This makes GlaxoSmithKline the world's 191th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GlaxoSmithKline from 2001 to 2023

End of year Market Cap

Year Market cap Change
2023$74.03 B2.91%
2022$71.93 B-34.07%
2021$109.10 B18.9%
2020$91.76 B-21.15%
2019$116.38 B23.9%
2018$93.93 B6.6%
2017$88.11 B-6.48%
2016$94.22 B-4.88%
2015$99.05 B-4.91%
2014$104.16 B-19.26%
2013$129.00 B21.97%
2012$105.76 B-8.18%
2011$115.19 B13.05%
2010$101.89 B-7.08%
2009$109.65 B13.45%
2008$96.66 B-30.35%
2007$138.78 B-8.6%
2006$151.83 B3.03%
2005$147.36 B4.74%
2004$140.69 B6.84%
2003$131.68 B16.71%
2002$112.83 B-26.62%
2001$153.76 B

End of Day market cap according to different sources

On Feb 6th, 2023 the market cap of GlaxoSmithKline was reported to be:

$72.34 Billion
by Yahoo Finance
$72.34 Billion
by CompaniesMarketCap
$72.33 Billion
by Nasdaq
$72.34 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$182.99 B 147.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$244.74 B 230.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$122.31 B 65.22%๐Ÿ‡ซ๐Ÿ‡ท France
$267.99 B 262.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$204.98 B 176.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
$12.10 B-83.65%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.46 B-98.02%๐Ÿ‡บ๐Ÿ‡ธ USA